vs

Side-by-side financial comparison of CME Group (CME) and PulteGroup (PHM). Click either name above to swap in a different company.

PulteGroup is the larger business by last-quarter revenue ($3.4B vs $1.9B, roughly 1.8× CME Group). PulteGroup runs the higher net margin — 10.2% vs 0.1%, a 10.1% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -12.4%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -13.9%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

PulteGroup, Inc. is an American residential home-construction company based in Atlanta, Georgia, United States. As of 2023, the company is the third-largest home-construction company in the United States based on the number of homes closed. In total, the company has built over 775,000 homes.

CME vs PHM — Head-to-Head

Bigger by revenue
PHM
PHM
1.8× larger
PHM
$3.4B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+26.9% gap
CME
14.5%
-12.4%
PHM
Higher net margin
PHM
PHM
10.1% more per $
PHM
10.2%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-13.9%
PHM

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
PHM
PHM
Revenue
$1.9B
$3.4B
Net Profit
$1.2M
$347.0M
Gross Margin
Operating Margin
0.1%
Net Margin
0.1%
10.2%
Revenue YoY
14.5%
-12.4%
Net Profit YoY
20.7%
-33.6%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
PHM
PHM
Q1 26
$1.9B
$3.4B
Q4 25
$1.6B
$4.6B
Q3 25
$1.5B
$4.4B
Q2 25
$1.7B
$4.4B
Q1 25
$1.6B
$3.9B
Q4 24
$1.5B
$4.9B
Q3 24
$1.6B
$4.5B
Q2 24
$1.5B
$4.6B
Net Profit
CME
CME
PHM
PHM
Q1 26
$1.2M
$347.0M
Q4 25
$1.2B
$501.6M
Q3 25
$908.0M
$585.8M
Q2 25
$1.0B
$608.5M
Q1 25
$956.2M
$522.8M
Q4 24
$874.6M
$913.2M
Q3 24
$912.8M
$697.9M
Q2 24
$883.2M
$809.1M
Gross Margin
CME
CME
PHM
PHM
Q1 26
Q4 25
Q3 25
27.8%
Q2 25
28.6%
Q1 25
28.8%
Q4 24
Q3 24
30.4%
Q2 24
31.4%
Operating Margin
CME
CME
PHM
PHM
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
Net Margin
CME
CME
PHM
PHM
Q1 26
0.1%
10.2%
Q4 25
71.7%
10.9%
Q3 25
59.1%
13.3%
Q2 25
60.6%
13.8%
Q1 25
58.2%
13.4%
Q4 24
57.3%
18.6%
Q3 24
57.6%
15.6%
Q2 24
57.6%
17.6%
EPS (diluted)
CME
CME
PHM
PHM
Q1 26
Q4 25
$3.24
$2.56
Q3 25
$2.49
$2.96
Q2 25
$2.81
$3.03
Q1 25
$2.62
$2.57
Q4 24
$2.40
$4.41
Q3 24
$2.50
$3.35
Q2 24
$2.42
$3.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
PHM
PHM
Cash + ST InvestmentsLiquidity on hand
$2.4B
$1.8B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$13.0B
Total Assets
$202.0B
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
PHM
PHM
Q1 26
$2.4B
$1.8B
Q4 25
$4.5B
$2.0B
Q3 25
$2.6B
$1.5B
Q2 25
$2.1B
$1.2B
Q1 25
$1.5B
$1.2B
Q4 24
$3.0B
$1.6B
Q3 24
$2.4B
$1.4B
Q2 24
$1.9B
$1.4B
Total Debt
CME
CME
PHM
PHM
Q1 26
$3.4B
Q4 25
$43.9M
Q3 25
Q2 25
Q1 25
Q4 24
$31.1M
Q3 24
Q2 24
Stockholders' Equity
CME
CME
PHM
PHM
Q1 26
$13.0B
Q4 25
$28.7B
$13.0B
Q3 25
$28.2B
$12.8B
Q2 25
$27.7B
$12.6B
Q1 25
$27.0B
$12.3B
Q4 24
$26.5B
$12.1B
Q3 24
$28.2B
$11.6B
Q2 24
$27.6B
$11.2B
Total Assets
CME
CME
PHM
PHM
Q1 26
$202.0B
$5.2B
Q4 25
$198.4B
$18.0B
Q3 25
$187.1B
$17.9B
Q2 25
$179.9B
$17.6B
Q1 25
$157.8B
$17.3B
Q4 24
$137.4B
$17.4B
Q3 24
$137.8B
$17.0B
Q2 24
$123.4B
$16.5B
Debt / Equity
CME
CME
PHM
PHM
Q1 26
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
PHM
PHM
Operating Cash FlowLast quarter
$159.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
0.46×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
PHM
PHM
Q1 26
$159.8M
Q4 25
$1.1B
$771.1M
Q3 25
$968.1M
$678.4M
Q2 25
$1.1B
$287.5M
Q1 25
$1.1B
$134.2M
Q4 24
$1.0B
$567.6M
Q3 24
$1.0B
$455.9M
Q2 24
$776.9M
$417.5M
Free Cash Flow
CME
CME
PHM
PHM
Q1 26
Q4 25
$1.1B
$739.8M
Q3 25
$949.7M
$651.1M
Q2 25
$1.0B
$253.0M
Q1 25
$1.1B
$104.6M
Q4 24
$991.7M
$543.1M
Q3 24
$973.2M
$417.2M
Q2 24
$758.7M
$386.2M
FCF Margin
CME
CME
PHM
PHM
Q1 26
Q4 25
66.8%
16.0%
Q3 25
61.8%
14.8%
Q2 25
61.5%
5.7%
Q1 25
67.1%
2.7%
Q4 24
65.0%
11.0%
Q3 24
61.4%
9.3%
Q2 24
49.5%
8.4%
Capex Intensity
CME
CME
PHM
PHM
Q1 26
0.7%
Q4 25
2.0%
0.7%
Q3 25
1.2%
0.6%
Q2 25
1.1%
0.8%
Q1 25
0.9%
0.8%
Q4 24
1.7%
0.5%
Q3 24
1.9%
0.9%
Q2 24
1.2%
0.7%
Cash Conversion
CME
CME
PHM
PHM
Q1 26
0.46×
Q4 25
0.96×
1.54×
Q3 25
1.07×
1.16×
Q2 25
1.03×
0.47×
Q1 25
1.17×
0.26×
Q4 24
1.16×
0.62×
Q3 24
1.10×
0.65×
Q2 24
0.88×
0.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

PHM
PHM

Home sale revenues$3.3B97%
Financial Services$71.7M2%
Land sale and other revenues$29.3M1%

Related Comparisons